Home / Business and Economy / Guardian Pharmacy Surges on Robust Q3 Earnings
Guardian Pharmacy Surges on Robust Q3 Earnings
14 Nov
Summary
- Guardian Pharmacy's Q3 revenue and earnings top estimates
- Company serves over 204,000 residents across 8,200 long-term care facilities
- Guardian aims to become the nation's leading long-term care pharmacy provider
On November 14, 2025, Guardian Pharmacy Services, a small-cap healthcare company, made headlines with its impressive third-quarter financial results. The $1.98 billion company, which had been consolidating for months, broke decisively higher following the release of its earnings report.
Guardian Pharmacy Services is a leading provider of technology-driven pharmacy management solutions for long-term care facilities across the United States. The company's mission is to promote health and wellness for older adults and those with complex care needs, while easing operational burdens for caregivers. As of November 2025, Guardian operates a network of over 53 pharmacies serving more than 204,000 residents across 8,200 long-term care facilities in 38 states.
Guardian's latest quarterly results exceeded expectations across the board. The company reported revenue of $377 million, easily beating analyst estimates of $354 million, and earnings per share (EPS) of 25 cents, one cent above consensus. Year-over-year, Guardian's revenue rose 20%, driven by a 13% increase in total residents served, a key growth metric that underscores the company's expanding reach and growing demand for its pharmacy solutions.
This strong performance has put Guardian Pharmacy Services on the radar of both traders and long-term investors, as the company continues to solidify its position as a leading player in the long-term care pharmacy services market.
